遺伝子発現解析の世界市場予測（～2023年）...市場調査レポートについてご紹介

TABLE OF CONTENTS

1 INTRODUCTION 18
1.1 OBJECTIVES OF THE STUDY 18
1.2 MARKET DEFINITION 18
1.3 MARKET SCOPE 19
1.3.1 MARKETS COVERED 19
1.3.2 YEARS CONSIDERED FOR THE STUDY 20
1.4 CURRENCY 20
1.5 LIMITATIONS 20
1.6 STAKEHOLDERS 20
2 RESEARCH METHODOLOGY 21
2.1 RESEARCH DATA 21
2.1.1 SECONDARY DATA 23
2.1.1.1 Key Data from Secondary Sources 23
2.1.2 PRIMARY DATA 24
2.1.2.1 Key Data from Primary Sources 25
2.1.2.2 Key Industry Insights 26
2.2 MARKET SIZE ESTIMATION METHODOLOGY 26
2.3 MARKET DATA ESTIMATION AND TRIANGULATION 28
2.4 ASSUMPTIONS FOR THE STUDY 29
3 EXECUTIVE SUMMARY 30
4 PREMIUM INSIGHTS 33
4.1 GENE EXPRESSION ANALYSIS MARKET OVERVIEW 33
4.2 EUROPEAN GENE EXPRESSION ANALYSIS MARKET, BY PRODUCT & SERVICE 34
4.3 GENE EXPRESSION ANALYSIS MARKET, BY PRODUCT & SERVICE, 2018 VS. 2023 35
4.4 GENE EXPRESSION ANALYSIS MARKET, BY END USER, 2018 VS. 2023 35
4.5 GEOGRAPHIC SNAPSHOT OF THE GENE EXPRESSION ANALYSIS MARKET 36
 
5 MARKET OVERVIEW 37
5.1 INTRODUCTION 37
5.2 MARKET DYNAMICS 37
5.2.1 DRIVERS 38
5.2.1.1 Decreasing cost of sequencing 38
5.2.1.2 Technological advancements 38
5.2.1.3 Rising prevalence of cancer 39
5.2.1.4 Availability of government funding 39
5.2.1.5 Novel technologies to aid gene expression studies 40
5.2.1.6 Growing application areas of gene expression 41
5.2.1.7 Availability of gene expression databases 41
5.2.2 RESTRAINTS 42
5.2.2.1 High cost of instruments 42
5.2.2.2 Shortage of trained professionals 42
5.2.3 OPPORTUNITIES 43
5.2.3.1 Emerging countries to provide growth opportunities 43
5.2.3.2 Growing use of gene expression analysis in precision medicine 43
5.2.4 CHALLENGES 44
5.2.4.1 Currency devaluation 44
6 GENE EXPRESSION ANALYSIS MARKET, BY PRODUCT & SERVICE 45
6.1 INTRODUCTION 46
6.2 CONSUMABLES 47
6.2.1 REAGENTS 48
6.2.1.1 Growth in overall research activity and instrument usage fuels the demand for reagents 48
6.2.2 DNA CHIPS 49
6.2.2.1 Technique limitations and growing preference for NGS have affected the demand for DNA chips 49
6.3 INSTRUMENTS 50
6.3.1 PCR INSTRUMENTS 51
6.3.1.1 Advent of enhanced DDPCR to aid the PCR market for gene expression 51
6.3.2 NEXT-GENERATION SEQUENCING INSTRUMENTS 52
6.3.2.1 NGS to overtake microarrays market in the coming years 52
6.3.3 DNA MICROARRAYS 53
6.3.3.1 Despite sluggish growth rate, DNA microarrays will witness sustained use in the coming years 53
6.3.4 OTHER INSTRUMENTS 54
 
6.4 SERVICES 55
6.4.1 GENE EXPRESSION PROFILING SERVICES 56
6.4.1.1 Sequencing services 58
6.4.1.1.1 Reduction in sequencing costs and technological advancements will drive demand for services 58
6.4.1.2 Other services 59
6.4.2 BIOINFORMATICS SOLUTIONS 59
6.4.2.1 Bioinformatics solutions enable researchers to manage and analyze large volumes of data 59
7 GENE EXPRESSION ANALYSIS MARKET, BY END USER 61
7.1 INTRODUCTION 62
7.2 PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES 63
7.2.1 INCREASING CLINICAL RESEARCH ON DRUG DISCOVERY AND BIOMARKER DEVELOPMENT TO SUPPORT THE GROWTH OF THIS END-USER SEGMENT 63
7.3 ACADEMIC INSTITUTES AND RESEARCH CENTERS 64
7.3.1 GROWING GOVERNMENT FUNDING TO DRIVE THE ADOPTION OF GENE EXPRESSION ANALYSIS TECHNIQUES IN ACADEMIC INSTITUTES AND RESEARCH CENTERS 64
7.4 OTHER END USERS 66
8 GENE EXPRESSION ANALYSIS MARKET, BY REGION 67
8.1 INTRODUCTION 68
8.2 NORTH AMERICA 70
8.2.1 US 73
8.2.1.1 Approvals of gene therapy products and favorable investments have driven R&D in this sector 73
8.2.2 CANADA 77
8.2.2.1 Recent CAD 21-million investment in GAPP will boost R&D into gene-based technologies 77
8.3 EUROPE 80
8.3.1 UK 84
8.3.1.1 Largest European market segment is a hub for NGS players and characterized by high availability of funds 84
8.3.2 GERMANY 87
8.3.2.1 Strong academic base and high scale of research ensure sustained demand for market products 87
8.3.3 ITALY 90
8.3.3.1 Government funding for life science research to aid the Italian market 90
8.3.4 SPAIN 93
8.3.4.1 An emerging market, but expected to witness strong growth in the coming years 93
 
8.3.5 FRANCE 96
8.3.5.1 Initiatives such as the French Plan for Genomic Medicine 2025 indicate a favorable market environment 96
8.3.6 REST OF EUROPE 99
8.4 ASIA PACIFIC 102
8.4.1 CHINA 106
8.4.1.1 Domestic manufacturing of sequencing systems to drive market growth in China 106
8.4.2 JAPAN 109
8.4.2.1 Increasing government focus on cancer research to drive market growth in Japan 109
8.4.3 AUSTRALIA 113
8.4.3.1 Increasing research activities in the fields of genetics and genomics to aid market growth in Australia 113
8.4.4 INDIA 116
8.4.4.1 Decreasing sequencing cost and growing prevalence of target diseases to support market growth in India 116
8.4.5 REST OF ASIA PACIFIC (ROAPAC) 119
8.5 REST OF THE WORLD (ROW) 122
8.5.1 GREATER ADOPTION OF GENETIC TESTING AND GENOMIC ANALYSIS TO DRIVE MARKET GROWTH IN THIS REGION 122
9 COMPETITIVE LANDSCAPE 128
9.1 OVERVIEW 128
9.2 MARKET RANKING OF PLAYERS, 2017 128
9.3 COMPETITIVE SCENARIO 129
9.3.1 PRODUCT LAUNCHES & APPROVALS 130
9.3.2 ACQUISITIONS 130
9.3.3 PARTNERSHIPS, AGREEMENTS, & COLLABORATIONS 131
10 COMPANY PROFILES 132
10.1 THERMO FISHER SCIENTIFIC, INC. 132
(Business Overview, Products & Services, Key Insights, Recent Developments, SWOT Analysis, MnM View)*
10.2 BIO-RAD LABORATORIES, INC. 136
10.3 ILLUMINA, INC. 139
10.4 AGILENT TECHNOLOGIES 143
10.5 F. HOFFMANN-LA ROCHE 148
10.6 GE HEALTHCARE 152
10.7 PERKINELMER, INC. 155
10.8 QIAGEN N.V. 158
10.9 OXFORD GENE TECHNOLOGY 163
10.10 PACIFIC BIOSCIENCES OF CALIFORNIA, INC. 165
 
10.11 BGI 167
10.12 EUROFINS SCIENTIFIC 169
*Details on Business Overview, Products & Services, Key Insights, Recent Developments, SWOT Analysis, MnM View might not be captured in case of unlisted companie
11 APPENDIX 172
11.1 DISCUSSION GUIDE 172
11.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 175
11.3 AVAILABLE CUSTOMIZATIONS 177
11.4 RELATED REPORTS 177
11.5 AUTHOR DETAILS 178